Reports for DOXORUBICIN HYDROCHLORIDE INJECTION
Brand name
DOXORUBICIN HYDROCHLORIDE INJECTION
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02409275 |
Ingredients
DOXORUBICIN HYDROCHLORIDE |
Ingredient Strength
2 MG |
ATC Code
L01DB |
ATC Descriptor
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
DOXORUBICIN HYDROCHLORIDE INJECTION | 25 | Resolved | 2022-11-14 | 2023-01-12 | 174595 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 5ml | Resolved | 2023-01-12 | 2023-10-06 | 180891 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 5ML | Resolved | 2023-06-16 | 2023-07-05 | 195219 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 100ML | Resolved | 2023-06-20 | 2023-10-19 | 195806 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0